Company Filing History:
Years Active: 1998-2004
Title: Wendell Doubleday: Innovator in Pharmaceutical Chemistry
Introduction
Wendell Doubleday is a notable inventor based in Encinitas, California. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on sulphonamide derivatives. With a total of 2 patents, his inventions have the potential to impact medical treatments.
Latest Patents
Doubleday's latest patents include the development of meta-substituted phenylene sulphonamide derivatives. This invention relates to a class of compounds represented by a specific formula, which can be utilized in pharmaceutical compositions. These compounds are designed to selectively inhibit or antagonize the .alpha..sub.v .beta..sub.3 integrin, showcasing their potential therapeutic applications.
Career Highlights
Wendell Doubleday has built a successful career at G.D. Searle & Company, where he has been instrumental in advancing pharmaceutical research. His work has contributed to the development of new treatments and has positioned him as a key figure in his field.
Collaborations
Throughout his career, Doubleday has collaborated with talented individuals such as Nizal S Chandrakumar and Michael John Clare. These partnerships have fostered innovation and have led to the successful development of his patented compounds.
Conclusion
Wendell Doubleday's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.